🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
Data of 100 patients with spinal metastatic tumor who received stereotactic...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2019-06-10
Trial ID
NCT03963713
The first hypothesis of the study is that substituting fentanyl by esmolol ...
Status
Completed
Location
Centre Hospitalier Universitaire de Sherbrooke
Start Date
2010-01
Trial ID
NCT01544959
Treatments Being Tested
The purpose of this study was to evaluate the feasibility of a multimodal p...
Status
Completed
Location
University Health Network
Start Date
2022-02-02
Trial ID
NCT04248959
Treatments Being Tested
The purpose of this study is to evaluate patient satisfaction and quality o...
Status
Enrolling By Invitation
Location
UC Davis Comprehensive Cancer Center
Start Date
2018-04-06
Trial ID
NCT03503240
This phase I trial studies the side effects and how well light dosimetry sy...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2021-09-17
Trial ID
NCT03678350
Treatments Being Tested
This study evaluates a new method of testing the lymph nodes in the armpit ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02610920
Treatments Being Tested
The purpose of this study is to determine the clinical utility of stool and...
Status
Terminated
Location
Westmead Endoscopy Unit
Start Date
2016-01-11
Trial ID
NCT02476682
Treatments Being Tested
The purpose of this study is to explore the influence of neoadjuvant chemot...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-04-17
Trial ID
NCT04408859
Treatments Being Tested
This is a Phase II, open-label, prospective, single-arm clinical study desi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-09-21
Trial ID
NCT06655259
Treatments Being Tested